Delivery Order SPE2DB24D2205-SPE2DB25FEFEB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on August 5, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Orgovyx 120 mg, with an ultimate completion date of August 11, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania, supporting federal pharmaceutical...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 units of Orgovyx 120 mg tablets, with an ultimate completion date of August 25, 2025. This non-set-aside contract was competitively awarded on August 4, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,385.52 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,542.08 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count unit of use packaging) on July 21, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,771.04 for 30 tablets of Orgovyx 120 mg on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is funded through the Medical Supply Chain, a defense-oriented federal agency supporting military and veteran healthcare systems. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units, with a contract ceiling value of $1,385.52. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This contract, valued at $4,156.56 with a firm fixed price structure, represents a non-set-aside competitive award with an ultimate completion date of August 22, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,385.52 firm fixed price delivery order for 30 tablets of Orgovyx 120 mg on August 4, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be performed at...
- The Defense Logistics Agency awarded a $1,385.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for Orgovyx 120 mg tablets (30-count units) under contract number 4568963001. The delivery order, awarded August 1, 2025, with completion targeted for August 22, 2025, represents a non-competitive, non-set-aside purchase. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFEBDelivery Order
The Defense Logistics Agency awarded a $4,156.56 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and represents a non-set-aside, competitively awarded contract. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health System. The company's extensive portfolio of federal contracts reflects its capability to supply a diverse range of pharmaceutical products—including specialty medications, biologics, and medical supplies—to support military healthcare programs globally. This particular award for Orgovyx, an advanced therapeutic pharmaceutical, demonstrates the company's continued role in fulfilling specialized medical supply needs for the Department of Defense and other federal healthcare entities through the DLA's pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 7/21/25 |